Outreach, Dissemination, and Training Core
外展、传播和培训核心
基本信息
- 批准号:10676279
- 负责人:
- 金额:$ 17.04万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-09-10 至 2026-07-31
- 项目状态:未结题
- 来源:
- 关键词:AccelerationAcuteAreaBioinformaticsChildhoodClinical PharmacologyCollaborationsCommunitiesCommunity SurveysDataData AnalysesData ScienceEducationEducational workshopFocus GroupsFosteringGoalsHealthIndianaIndividualKnowledgeLinkMedicineModelingMonitorNational Institute of Child Health and Human DevelopmentOhioPediatric ResearchPerformancePersonsPharmacogenomicsPharmacologyPrivatizationPublicationsResearchResearch PersonnelResourcesScienceSurveysTherapeuticTherapeutic ResearchTrainingTraining ProgramsTranslational ResearchUniversitiesclinical caredata disseminationdrug developmentimprovedinnovationmeetingsmembernext generationonline tutorialoutreachpediatric pharmacologypharmacometricsscientific hubskillssocial mediasuccesssymposiumtooltraining opportunityvirtualweb sitewebinar
项目摘要
The Outreach, Dissemination and Training Core (Outreach Core) of the Indiana University-Ohio State
University Maternal and Pediatric Precision in Therapeutics Data, Model, Knowledge, and Research
Coordination Center (IU-OSU MPRINT DMKRCC) will serve as a conduit between the MPRINT Hub and the
broader scientific community. The Outreach Core will facilitate interactions with external partners to enhance
knowledge, research, and educational efforts in maternal and pediatric therapeutics. The aims of the Outreach
Core include: 1) Working in concert with other KRCC cores and the MPRINT CETs, develop a centralized
MPRINT Hub website and identity, coordinate timely dissemination of data through the MPRINT Hub and
promote, monitor, and evaluate utilization of the MPRINT Hub; 2) Promote the MPRINT Hub to researchers,
clinicians, and the public by organizing an annual MPRINT Hub scientific meeting, presentations at scientific
meetings, through publications, and over social media in order to expand maternal-pediatric clinical
pharmacology research and foster collaborations with public and private research partners; and 3) Develop,
disseminate, and conduct training opportunities for individuals within and beyond the MPRINT Hub to develop
skills in maternal and pediatric pharmacology, pharmacometrics, pharmacogenomics, data science, and drug
development. Such opportunities will include workshops at scientific meetings and the annual MPRINT Hub
scientific meeting, webinars and online tutorials, which will be made freely available through the MPRINT Hub
website and the NICHD’s Virtual Network for pharmacology trainees. The Outreach Core will also survey the
community to help identify gaps in knowledge and research tools as well as the success of the MPRINT Hub to
satisfy the needs of the maternal and pediatric therapeutic research community. Additionally, the Outreach
Core will maintain and evaluate usage of the MPRINT Hub Website and social media platforms, and
coordinate with the MPRINT Hub Steering Committee to reprioritize activities and set milestones for
performance. Through these activities, the Outreach Core will promote the resources provided by the MPRINT
Hub in order to accelerate research in maternal and pediatric therapeutics.
印第安纳州大学俄亥俄州立分校的外展、传播和培训中心(外展中心)
治疗学数据、模型、知识和研究中的大学孕产妇和儿科精确度
协调中心(IU-OSU MPRINT DMKRCC)将作为MPRINT中心和
更广泛的科学界。外联核心将促进与外部伙伴的互动,
知识,研究和教育工作在孕产妇和儿科治疗。外联的目标
核心包括:1)与其他KRCC核心和MPRINT CET协同工作,开发一个集中的
MPRINT Hub网站和身份,通过MPRINT Hub协调数据的及时传播,
促进、监测和评估MPRINT中心的利用; 2)向研究人员推广MPRINT中心,
临床医生和公众通过组织年度MPRINT中心科学会议,在科学
会议,通过出版物和社交媒体,以扩大母婴临床
药理学研究和促进与公共和私人研究伙伴的合作;和3)发展,
在MPRINT中心内外为个人提供传播和培训机会,以发展
孕产妇和儿科药理学,药物计量学,药物基因组学,数据科学和药物
发展此类机会将包括科学会议上的研讨会和年度MPRINT中心
科学会议,网络研讨会和在线教程,将通过MPRINT Hub免费提供
网站和NICHD的药理学实习生虚拟网络。外联核心还将调查
社区,以帮助确定知识和研究工具的差距,以及MPRINT中心的成功,
满足孕产妇和儿科治疗研究社区的需求。此外,外联
核心将维护和评估MPRINT Hub网站和社交媒体平台的使用情况,
与MPRINT中心指导委员会协调,重新确定活动的优先级,并设定里程碑,
性能通过这些活动,“外联核心”将促进由“伙伴关系报告”提供的资源,
中心,以加快研究在孕产妇和儿科治疗。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Sara K Quinney其他文献
Sara K Quinney的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Sara K Quinney', 18)}}的其他基金
Integrated bioinformatic and pharmacokinetic models of high-dimensional drug interactions
高维药物相互作用的综合生物信息学和药代动力学模型
- 批准号:
9008147 - 财政年份:2016
- 资助金额:
$ 17.04万 - 项目类别:
Individualization of nifedipine dosing for preterm labor
早产硝苯地平剂量的个体化
- 批准号:
8383153 - 财政年份:2012
- 资助金额:
$ 17.04万 - 项目类别:
相似海外基金
Transcriptional assessment of haematopoietic differentiation to risk-stratify acute lymphoblastic leukaemia
造血分化的转录评估对急性淋巴细胞白血病的风险分层
- 批准号:
MR/Y009568/1 - 财政年份:2024
- 资助金额:
$ 17.04万 - 项目类别:
Fellowship
Combining two unique AI platforms for the discovery of novel genetic therapeutic targets & preclinical validation of synthetic biomolecules to treat Acute myeloid leukaemia (AML).
结合两个独特的人工智能平台来发现新的基因治疗靶点
- 批准号:
10090332 - 财政年份:2024
- 资助金额:
$ 17.04万 - 项目类别:
Collaborative R&D
Acute senescence: a novel host defence counteracting typhoidal Salmonella
急性衰老:对抗伤寒沙门氏菌的新型宿主防御
- 批准号:
MR/X02329X/1 - 财政年份:2024
- 资助金额:
$ 17.04万 - 项目类别:
Fellowship
Cellular Neuroinflammation in Acute Brain Injury
急性脑损伤中的细胞神经炎症
- 批准号:
MR/X021882/1 - 财政年份:2024
- 资助金额:
$ 17.04万 - 项目类别:
Research Grant
KAT2A PROTACs targetting the differentiation of blasts and leukemic stem cells for the treatment of Acute Myeloid Leukaemia
KAT2A PROTAC 靶向原始细胞和白血病干细胞的分化,用于治疗急性髓系白血病
- 批准号:
MR/X029557/1 - 财政年份:2024
- 资助金额:
$ 17.04万 - 项目类别:
Research Grant
Combining Mechanistic Modelling with Machine Learning for Diagnosis of Acute Respiratory Distress Syndrome
机械建模与机器学习相结合诊断急性呼吸窘迫综合征
- 批准号:
EP/Y003527/1 - 财政年份:2024
- 资助金额:
$ 17.04万 - 项目类别:
Research Grant
FITEAML: Functional Interrogation of Transposable Elements in Acute Myeloid Leukaemia
FITEAML:急性髓系白血病转座元件的功能研究
- 批准号:
EP/Y030338/1 - 财政年份:2024
- 资助金额:
$ 17.04万 - 项目类别:
Research Grant
STTR Phase I: Non-invasive focused ultrasound treatment to modulate the immune system for acute and chronic kidney rejection
STTR 第一期:非侵入性聚焦超声治疗调节免疫系统以治疗急性和慢性肾排斥
- 批准号:
2312694 - 财政年份:2024
- 资助金额:
$ 17.04万 - 项目类别:
Standard Grant
ロボット支援肝切除術は真に低侵襲なのか?acute phaseに着目して
机器人辅助肝切除术真的是微创吗?
- 批准号:
24K19395 - 财政年份:2024
- 资助金额:
$ 17.04万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Acute human gingivitis systems biology
人类急性牙龈炎系统生物学
- 批准号:
484000 - 财政年份:2023
- 资助金额:
$ 17.04万 - 项目类别:
Operating Grants














{{item.name}}会员




